How severe is CVE-2023-27875?

CVE-2023-27875 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.

Is CVE-2023-27875 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (42nd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-27875?

CVE-2023-27875 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-27875?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2023-27875 published?

CVE-2023-27875 was published on 2023-03-16 and last updated on 2026-06-17.

CVE-2023-27875

CVE-2023-27875 is a high-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-284.

Key facts

Severity: High (CVSS 3.x base score 7.5)
EPSS exploit prediction: 1% (42nd percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-284
Affected product: Ibm Aspera Faspex
Published: 2023-03-16
Last modified: 2026-06-17

Description

IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM X-Force ID: 249847.

Frequently asked questions

What is CVE-2023-27875?: IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM X-Force ID: 249847.
How severe is CVE-2023-27875?: CVE-2023-27875 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.
Is CVE-2023-27875 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (42nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-27875?: CVE-2023-27875 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-27875?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-27875 published?: CVE-2023-27875 was published on 2023-03-16 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:ibm:aspera_faspex:5.0.4:*:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Faspex

CVE-2023-27874 — Critical (CVSS 9.9): IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A…
CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…
CVE-2023-30995 — High (CVSS 7.5): IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist…
CVE-2023-27871 — High (CVSS 7.5): IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user,…
CVE-2022-22497 — High (CVSS 7.5): IBM Aspera Faspex 4.4.1 and 5.0.0 could allow unauthorized access due to an incorrectly computed security token. IBM…

All CVEs affecting Ibm Aspera Faspex →

Other CWE-284 (Improper Access Control) vulnerabilities

CVE-2026-50746 — Critical (CVSS 10.0): A malicious actor with access to the network could exploit an Improper Access Control vulnerability found in UniFi…
CVE-2026-46978 — Critical (CVSS 10.0): Vulnerability in the Oracle Solaris product of Oracle Systems (component: Remote Administration Daemon). The…
CVE-2026-35308 — Critical (CVSS 10.0): Vulnerability in the Oracle Coherence product of Oracle Fusion Middleware (component: Centralized Third Party Jars).…
CVE-2026-35307 — Critical (CVSS 10.0): Vulnerability in the Oracle Coherence product of Oracle Fusion Middleware (component: Core). Supported versions that…
CVE-2026-46695 — Critical (CVSS 10.0): Boxlite is a sandbox service that allows users to create lightweight virtual machines (Boxes) and launch OCI containers…
CVE-2026-46840 — Critical (CVSS 10.0): Vulnerability in Oracle REST Data Services (component: Backend-as-a-Service). Supported versions that are affected are…

Browse all CWE-284 (Improper Access Control) vulnerabilities →